Tag: monitoring

BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY^®▼(nipocalimab) throughout clinically relevant points in the generalised myasthenia gravis (gMG) treatment journey. The analyses include adults with anti-AChR^a or anti-MuSK^b antibody-positive gMG who were early in their disease course or had lower baseline symptom burden – providing insight into the potential importance of addressing pathogenic immunoglobulin G (IgG) early in disease progression where use of advanced therapies may be less common.^1,2 Additional research to be shared include outcomes shortly after common infections, which are a known cause of disease exacerbations in gMG, and plans to address evidence gaps in the use of nipocalimab during pregnancy.^3,4

London, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) --

BulkQuant, a fully managed AI trading robot platform, is expanding its automated trading ecosystem to help retail investors explore structured trading strategies across cryptocurrency, forex, and stock market environments.

MONACO, June 26, 2026 (GLOBE NEWSWIRE) -- Monaco is set to become a global laboratory for the future of sustainable maritime mobility once again. The 13th Monaco Energy Boat Challenge is fast approaching and will bring together students, researchers, engineers, shipyards and technology companies from around the world next month to showcase the latest advances in clean propulsion systems. With 52 teams from 21 nationalities, representing 33 competing universities, while 14 additional universities will attend as observers, the event has become one of the leading international platforms for innovation in the maritime sector.

HONG KONG, June 26, 2026 (GLOBE NEWSWIRE) -- CoinEx has issued a detailed public response following a recent Wall Street Journal report discussing the exchange’s historical exposure to Iran-related cryptocurrency transactions, rejecting suggestions that it maintained commercial relationships with sanctioned Iranian entities while outlining a series of compliance enhancements implemented in recent months.

Additional Orders Triple Implementation Scale; "MOTHER Bracelet®" Enables Continuous Safety Monitoring During Extended Training

 ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production